Dr. Preethy Paul
CEO, Co-Founder & Board Member
Preethy, the CEO, is a key force behind the discovery. With a background in cell biology and over a decade of experience in HPV research, she has contributed to three patents and numerous peer-reviewed publications. Alongside her scientific expertise, she has extensive experience in commercialization and holds an MBA in Business Management from Turku University of Applied Sciences.
paul.preethy@anisontherapeutics.com
Dr. Senthil Kumar Rajendran
CEO, Co-Founder & Board Member
Senthil, a key figure in product development and supply chain management, holds a Ph.D. in Medicinal Chemistry and brings over 15 years of research experience in drug development. He has published more than 26 peer-reviewed articles and has played a pivotal role in product design and development for multiple Business Finland and Novo Nordisk-funded projects.
senthil.rajendran@anisontherapeutics.com
Dr. Kenneth Sundberg
COO, Co-Founder
Kenneth has over 20 years of experience in commercializing research and product development in companies such as Ciba, Hormos Nutraceuticals, BASF and Tikkurila. He holds an Associate Professorship in Forest Products Chemistry at Åbo Akademi University. In his free-time, Kenneth is always up for a tennis challenge.
senthil.rajendran@anisontherapeutics.com
Jaakko Ollila
Chairman of Board
Experienced engineer with background from building companies across different sectors since year 2000. Founder or investor in several businesses, incl CRF Health, Booxmedia (now part of 24i), Naava, Synoste and Kaiku Health. Jaakko speaks five languages, and likes to spend his free-time reading history books or playing racket sports.
jaakko.ollila@gmail.com
Prof. John Eriksson
Co-Founder & Board Member
John leads the research team behind the discovery. He is a Professor in Cell Biology and Director General of the Euro-Bioimaging Hub Office in Turku. John played a crucial role in establishing Euro-BioImaging, demonstrating his significant contributions to both research and infrastructure development
john.eriksson@abo.fi
Dr. Lasse Leino
Board Member
Dr. Leino, President and CEO of DelSiTech, has over 25 years of experience in the life sciences industry. He holds a PhD in biochemistry and serves as an Adjunct Professor of immunology at the University of Turku, bringing deep expertise in both business and academic research.
lasse.leino@delsitech.com
Reko Leino
Board Member
Prof. Reko Leino, Vice-rector at Åbo Akademi University, is an experienced professor and innovator with a strong background in academia and the biopharmaceutical industry. He is highly skilled in synthetic chemistry and drug development research, bringing extensive expertise in advancing biopharmaceutical technologies.
reko.leino@abo.fi